| Subject Area | Rank | Percentile |
|---|---|---|
| Category: Medicine Subcategory: Oncology |
7 / 415 |
| APC | APC Waiver | Other Charges |
|---|---|---|
| N/A | N/A | N/A |
| Quartiles By JIF | Collection | Quartile | Rank | Percentage |
| Category: ONCOLOGY | SCIE | Q1 | 8/326 |
|
| Quartiles By JCI | Collection | Quartile | Rank | Percentage |
| Category: ONCOLOGY | SCIE | Q1 | 4/326 |
|
| Journal Title | h-index | CiteScore |
|---|---|---|
| CA-A CANCER JOURNAL FOR CLINICIANS | 144 | 1154.20 |
| Nature Reviews Clinical Oncology | 127 | 114.50 |
| NATURE REVIEWS CANCER | 396 | 103.80 |
| ANNALS OF ONCOLOGY | 210 | 70.40 |
| CANCER CELL | 295 | 57.70 |
| JOURNAL OF CLINICAL ONCOLOGY | 494 | 38.90 |
| CANCER RESEARCH | 411 | 17.80 |
| SEMINARS IN CANCER BIOLOGY | 134 | 35.00 |
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 67 | 20.20 |
| CANCER TREATMENT REVIEWS | 116 | 17.10 |
Select your rating and start your review of LANCET ONCOLOGY
2024-07-16
The basic article is being received.
2024-06-19
Review speed: 3.0 | Submission hit rate: 5.0 Emphasis on research directions: tumors; tumor immunotherapy; solid tumor experience sharing: The impact factor for the year 2023 is 41.6, which is still good overall and still in a leading position in the field of oncology. CA-A CANCER JOURNAL FOR CLINICIANS, 503.1, dominates with one article, without considering Nature Reviews Clinical Oncology 81.3, mainly publishes reviews. ANNALS OF ONCOLOGY, 56.7, mainly reviews. CANCER CELL 48.8, mainly focuses on translational medicine, and starting from the past two years, also publishes some clinical trial articles. JOURNAL OF CLINICAL ONCOLOGY, 42.1, is similar to LANCET ONCOLOGY, ranking equally. Moving down, Cancer Discovery, 29.7, also publishes articles on basic research and translational medicine, which are further from clinical practice. Journal of Hematology & Oncology 29.5 is a comprehensive journal for hematologic tumors and solid tumors. Molecular Cancer 27.7 is also related to tumor translational medicine.
2024-06-08
Please translate the following passage into English: 8
2023-07-18
Haha, the road of scientific research is long in life
2023-07-18
The Lancet journal is fine as long as the article is good. If the journal invites submissions, it can still be accepted
2023-06-28
Impact factor of 51.1, top journal
2023-05-26
Submitting articles every day, worrying every day
2023-05-03
It's best
2022-11-06
Looking forward, multicenter is the mainstream, everything else is outdated
2022-03-30
The editor was very nice, although my submission was ultimately rejected. However, the rejection letter was sincere and included substantive feedback specific to my article. In the end, they recommended another journal and suggested transferring my submission there.
